Ranbaxy Laboratories gets Supreme Court salve on 'substandard drugs' PIL

RanbaxyNo material has been placed to show that drugs manufactured by Ranbaxy are substandard. (Reuters)

Supreme Court today dismissed a PIL seeking a probe against Ranbaxy Laboratories Ltd for allegedly manufacturing and selling substandard medicines due to lack of evidence against the company.

A bench of justices A K Patnaik and Ranjan Gogoi, however, allowed the petitioner advocate M L Sharma to file a fresh petition if he finds some evidence against the company in support of his allegation that the company is engaged in manufacturing and selling substandard drugs.

* BSE Sensex

* NSE Nifty

The bench said that it cannot decide the plea against the company on the basis of a judgement passed by a US court against Ranbaxy.

"Your entire argument is based on proceedings in US. We have no jurisdiction over it. Show us material that things are happening in India and it adversely affects right to life of people here," the bench observed adding, "Where is the material against Ranbaxy".

"No material has been placed to show that drugs manufactured by any unit of Ranbaxy are substandard,adulterated, spurious and that such drugs are prohibited under the law. In absence of such material, we cannot entertain the plea," the bench said.

In his PIL, Sharma had alleged that Ranbaxy was fined USD 500 million by the US Food and Drug Administration (USFDA) for making and selling "adulterated" drugs. It also sought sealing of all its manufacturing units here, including those in Paonta

Sahib in Himachal Pradesh and Dewas in Madhya Pradesh.

He alleged that despite Ranbaxy pleading guilty to supplying adulterated drugs in the US and it being fined such a huge amount, the Centre has not taken any action to prohibit or ban the drugs made by the company.

He also sought action against Indian drug regulator, Central Drug Standards Control Organisation (CDSCO), for permitting Ranbaxy to sell drugs in India, especially in the wake of the results of the USFDA probe against the company.

Please read our terms of use before posting comments
TERMS OF USE: The views expressed in comments published on indianexpress.com are those of the comment writer's alone. They do not represent the views or opinions of The Indian Express Group or its staff. Comments are automatically posted live; however, indianexpress.com reserves the right to take it down at any time. We also reserve the right not to publish comments that are abusive, obscene, inflammatory, derogatory or defamatory.